Published in Nat Methods on October 26, 2015
Systematic mapping of functional enhancer-promoter connections with CRISPR interference. Science (2016) 1.57
CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science (2016) 1.51
CRISPR/Cas9 editing of induced pluripotent stem cells for engineering inflammation-resistant tissues. Arthritis Rheumatol (2016) 1.39
Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat Methods (2016) 1.24
Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation. Nat Rev Mol Cell Biol (2015) 1.20
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes. Cell (2016) 1.08
CRISPR-Cas: biology, mechanisms and relevance. Philos Trans R Soc Lond B Biol Sci (2016) 0.93
Directing cellular information flow via CRISPR signal conductors. Nat Methods (2016) 0.84
Loss-of-function genetic tools for animal models: cross-species and cross-platform differences. Nat Rev Genet (2016) 0.82
Understanding Spatial Genome Organization: Methods and Insights. Genomics Proteomics Bioinformatics (2016) 0.82
Genome editing comes of age. Nat Protoc (2016) 0.81
Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase. Nucleic Acids Res (2016) 0.81
Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies? Mol Oncol (2016) 0.81
Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner. Nat Commun (2016) 0.80
A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells. Nat Methods (2017) 0.79
Cas9 Functionally Opens Chromatin. PLoS One (2016) 0.79
Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits. Epigenetics Chromatin (2016) 0.79
CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome. Nat Biotechnol (2017) 0.78
Applications of CRISPR Genome Engineering in Cell Biology. Trends Cell Biol (2016) 0.78
Precision Modulation of Neurodegenerative Disease-Related Gene Expression in Human iPSC-Derived Neurons. Sci Rep (2016) 0.78
Optimizing sgRNA position markedly improves the efficiency of CRISPR/dCas9-mediated transcriptional repression. Nucleic Acids Res (2016) 0.78
Complex transcriptional modulation with orthogonal and inducible dCas9 regulators. Nat Methods (2016) 0.78
The epigenomics of schizophrenia, in the mouse. Am J Med Genet B Neuropsychiatr Genet (2017) 0.77
A genome editing primer for the hematologist. Blood (2016) 0.77
Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications. Curr Opin Biotechnol (2016) 0.77
N-cadherin is Key to Expression of the Nucleus Pulposus Cell Phenotype under Selective Substrate Culture Conditions. Sci Rep (2016) 0.77
The epigenome: the next substrate for engineering. Genome Biol (2016) 0.77
Generalized nucleation and looping model for epigenetic memory of histone modifications. Proc Natl Acad Sci U S A (2016) 0.76
Genome editing: the end of the beginning. Genome Biol (2015) 0.76
Applying CRISPR-Cas9 tools to identify and characterize transcriptional enhancers. Nat Rev Mol Cell Biol (2016) 0.76
Genome-scale CRISPR pooled screens. Anal Biochem (2016) 0.75
Genome engineering of stem cell organoids for disease modeling. Protein Cell (2017) 0.75
Genome Engineering with TALE and CRISPR Systems in Neuroscience. Front Genet (2016) 0.75
Genetic and epigenetic control of gene expression by CRISPR-Cas systems. F1000Res (2017) 0.75
Role of MYC in B Cell Lymphomagenesis. Genes (Basel) (2017) 0.75
New tools for experimental diabetes research: Cellular reprogramming and genome editing. Ups J Med Sci (2016) 0.75
Engineering of temperature- and light-switchable Cas9 variants. Nucleic Acids Res (2016) 0.75
CRISPR-Mediated Epigenome Editing. Yale J Biol Med (2016) 0.75
CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases. Oncotarget (2016) 0.75
How to Train a Cell-Cutting-Edge Molecular Tools. Front Chem (2017) 0.75
Decoding transcriptional enhancers: Evolving from annotation to functional interpretation. Semin Cell Dev Biol (2016) 0.75
Emerging roles for long noncoding RNAs in skeletal biology and disease. Connect Tissue Res (2016) 0.75
Re-engineered RNA-Guided FokI-Nucleases for Improved Genome Editing in Human Cells. Mol Ther (2017) 0.75
Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas. Oncotarget (2016) 0.75
Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will. Curr Genet Med Rep (2016) 0.75
Survival and Evolution of CRISPR-Cas System in Prokaryotes and Its Applications. Front Immunol (2016) 0.75
Molecular structures guide the engineering of chromatin. Nucleic Acids Res (2017) 0.75
CRISPR/Cas9-Mediated Scanning for Regulatory Elements Required for HPRT1 Expression via Thousands of Large, Programmed Genomic Deletions. Am J Hum Genet (2017) 0.75
Emerging Gene Therapies for Genetic Hearing Loss. J Assoc Res Otolaryngol (2017) 0.75
Ethanol exposure regulates Gabra1 expression via histone deacetylation at the promoter in cultured cortical neurons. J Pharmacol Exp Ther (2017) 0.75
Reconstruction of enhancer-target networks in 935 samples of human primary cells, tissues and cell lines. Nat Genet (2017) 0.75
Evaluating Synthetic Activation and Repression of Neuropsychiatric-Related Genes in hiPSC-Derived NPCs, Neurons, and Astrocytes. Stem Cell Reports (2017) 0.75
Characterization of noncoding regulatory DNA in the human genome. Nat Biotechnol (2017) 0.75
dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression. Nucleic Acids Res (2017) 0.75
Genome engineering: a new approach to gene therapy for neuromuscular disorders. Nat Rev Neurol (2017) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
Fast gapped-read alignment with Bowtie 2. Nat Methods (2012) 83.79
An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73
Differential expression analysis for sequence count data. Genome Biol (2010) 64.56
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics (2010) 53.23
Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol (2014) 27.48
The accessible chromatin landscape of the human genome. Nature (2012) 16.86
High-resolution mapping and characterization of open chromatin across the genome. Cell (2008) 15.93
Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res (2006) 13.32
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell (2013) 9.55
SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev (2002) 8.78
Optical control of mammalian endogenous transcription and epigenetic states. Nature (2013) 6.09
Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1. Mol Cell (2005) 5.77
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell (2014) 5.43
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature (2014) 5.19
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat Biotechnol (2014) 5.07
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
CRISPR RNA-guided activation of endogenous human genes. Nat Methods (2013) 4.69
Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat Biotechnol (2014) 4.16
Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev (2003) 3.95
Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci U S A (2000) 3.92
Locus-specific editing of histone modifications at endogenous enhancers. Nat Biotechnol (2013) 3.82
Locus control regions of mammalian beta-globin gene clusters: combining phylogenetic analyses and experimental results to gain functional insights. Gene (1997) 3.77
Dynamics and memory of heterochromatin in living cells. Cell (2012) 3.75
Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nat Commun (2012) 3.60
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol (2015) 3.56
DNase-seq: a high-resolution technique for mapping active gene regulatory elements across the genome from mammalian cells. Cold Spring Harb Protoc (2010) 3.54
The KAP1 corepressor functions to coordinate the assembly of de novo HP1-demarcated microenvironments of heterochromatin required for KRAB zinc finger protein-mediated transcriptional repression. Mol Cell Biol (2006) 2.93
Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol (2013) 2.89
KRAB-zinc finger proteins and KAP1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genet (2010) 2.44
Inducible transcription of five globin genes in K562 human leukemia cells. Proc Natl Acad Sci U S A (1983) 2.35
Functional annotation of native enhancers with a Cas9-histone demethylase fusion. Nat Methods (2015) 2.22
Transcription of the hypersensitive site HS2 enhancer in erythroid cells. Proc Natl Acad Sci U S A (1992) 2.20
NuRD-mediated deacetylation of H3K27 facilitates recruitment of Polycomb Repressive Complex 2 to direct gene repression. EMBO J (2011) 2.09
Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol Cell (2014) 2.02
Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo. Curr Biol (2002) 1.90
Highly efficient Cas9-mediated transcriptional programming. Nat Methods (2015) 1.81
Transposase mediated construction of RNA-seq libraries. Genome Res (2011) 1.66
Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics (2012) 1.65
Reactivation of developmentally silenced globin genes by forced chromatin looping. Cell (2014) 1.64
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector. Nucleic Acids Res (2014) 1.59
Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers. Nucleic Acids Res (2014) 1.25
A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture. Nucleic Acids Res (2015) 1.20
A CRISPR/Cas9-based system for reprogramming cell lineage specification. Stem Cell Reports (2014) 1.09
Levels of GATA-1/GATA-2 transcription factors modulate expression of embryonic and fetal hemoglobins. Gene (2000) 1.02
Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin. Mol Cell Biol (1999) 0.98
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation. Nucleic Acids Res (2014) 0.95
Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators. Genome Res (2015) 0.92
Genome-editing Technologies for Gene and Cell Therapy. Mol Ther (2016) 1.41
Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nat Methods (2016) 1.24
CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome. Nat Biotechnol (2017) 0.78